Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-21
1988-09-13
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546123, 546156, 548566, 562433, 260544R, C07D21556, A61K 3147
Patent
active
047710551
ABSTRACT:
Novel, orally active antibacterial agents are described and characterized as 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-6-fluoro-1,4-dihydro-4-oxo -3-quinoline carboxylic acids or corresponding 1,8-naphthyridine derivatives as well as methods for their manufacture.
REFERENCES:
patent: 4665079 (1987-05-01), Culbertson et al.
Chemical Abstracts No. 196274s, vol. 106 for JP 30776, (2/9/87).
Chemical Abstract for Japan Kokai 61,126,082, (6/13/86), Matsumoto et al., #106:4995h, (1987).
Domagala John M.
Hagen Susan E.
Sanchez Joseph P.
Bernhardt E.
Daignault Ronald A.
Daus Donald G.
Warner-Lambert & Company
LandOfFree
7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxyli does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxyli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxyli will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-807153